Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Bioactive and Compatible Polymers
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lemmouchi, Y.
Right arrow Articles by Schacht, E.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In Vitro Evaluation of Poly-({epsilon}-Caprolactone-Co-L-Lactide) Implants Containing Trypanocidal Drugs

Yahia Lemmouchi

Polymer Materials Research Group, Institute for Biomedical Technologies, IBITECH, University of Gent, Krigslaan 281 B-9000 Gent, Belgium

Etienne Schacht

Polymer Materials Research Group, Institute for Biomedical Technologies, IBITECH, University of Gent, Krigslaan 281 B-9000 Gent, Belgium

Poly(e-caprolactone-co-L-lactide) copolyesters with different compositions were synthesized by bulk polymerization. The copolymers were characterized by NMR, GPC, and DSC analyses. Slow release devices were obtained as rods by extrusing polymer/drug mixtures (75/25, w/w) prepared by solution casting. The rods were coated by dipping in a methylene chloride solution of the core polymer. The in vitro release of isometamidium chloride (IMM) and ethidium bromide (EtBr), from these rods was carried out in phosphate buffer (PB) pH 7.4 at 3700. The release of IMM is faster than for EtBr. Initial IMM release is governed by osmotic pressure, whereas EtBr release is mainly diffusion controlled. The in vitro release of these drugs is governed by polymer matrix degradation at the later stage of the release process. The in vitro release of IMM from these copolymers depends on polymer composition and coating thickness. The in vitro release of EtBr may be controlled by polymer composition, polymer molecular weight, coating thickness, and device geometry.

Journal of Bioactive and Compatible Polymers, Vol. 12, No. 3, 175-185 (1997)
DOI: 10.1177/088391159701200301
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?